Acurx Pharmaceuticals announced plans to allocate up to $1 million worth of Bitcoin for its treasury reserves. This decision aligns with the growing interest among companies in cryptocurrencies as an alternative financial strategy.
Why Acurx is Investing in Bitcoin
Acurx Pharmaceuticals' board of directors approved the decision to allocate up to $1 million in Bitcoin as a strategic move reflecting the trend of increasing adoption of cryptocurrencies as an important asset.
CEO's Statement
Acurx CEO David P. Luci highlighted that Bitcoin's limited supply and inflation-resistant properties make it a suitable store of value.
Parallels with MicroStrategy
Acurx's decision mirrors the strategy of MicroStrategy, which began investing in Bitcoin in 2020. Acurx aims to achieve similar success and stock growth through such a strategy.
Acurx's decision to invest in Bitcoin is part of a broader financial strategy reflecting the increasing acceptance of cryptocurrencies as a significant asset. The company emphasizes maintaining its core activities in drug development.
